Joseph Kambeitz

ORCID: 0000-0002-8988-3959
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Functional Brain Connectivity Studies
  • Schizophrenia research and treatment
  • Mental Health Research Topics
  • Advanced Neuroimaging Techniques and Applications
  • Tryptophan and brain disorders
  • Mental Health and Psychiatry
  • Child and Adolescent Psychosocial and Emotional Development
  • Neurotransmitter Receptor Influence on Behavior
  • Bipolar Disorder and Treatment
  • Neural and Behavioral Psychology Studies
  • Treatment of Major Depression
  • Psychosomatic Disorders and Their Treatments
  • Neuroscience and Neuropharmacology Research
  • Child Abuse and Trauma
  • Cannabis and Cannabinoid Research
  • Health, Environment, Cognitive Aging
  • Attention Deficit Hyperactivity Disorder
  • Machine Learning in Healthcare
  • Neuroscience and Music Perception
  • Health Systems, Economic Evaluations, Quality of Life
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Neurological disorders and treatments
  • Genetic Associations and Epidemiology
  • Neural dynamics and brain function
  • Diet and metabolism studies

University of Cologne
2019-2025

University Hospital Cologne
2019-2025

Ludwig-Maximilians-Universität München
2013-2024

ORCID
2024

Authorised Association Consortium
2024

TH Köln - University of Applied Sciences
2023

Forschungszentrum Jülich
2022-2023

Gold Skin Care Center
2018-2019

LMU Klinikum
2010-2018

King's College London
2010-2015

Social and occupational impairments contribute to the burden of psychosis depression. There is a need for risk stratification tools inform personalized functional-disability preventive strategies individuals in at-risk early phases these illnesses.To determine whether predictors associated with social role functioning can be identified patients clinical high-risk (CHR) states or recent-onset depression (ROD) using clinical, imaging-based, combined machine learning; assess geographic,...

10.1001/jamapsychiatry.2018.2165 article EN JAMA Psychiatry 2018-09-29

Diverse models have been developed to predict psychosis in patients with clinical high-risk (CHR) states. Whether prediction can be improved by efficiently combining and biological broadening the risk spectrum young depressive syndromes remains unclear.To evaluate whether transition predicted CHR or recent-onset depression (ROD) using multimodal machine learning that optimally integrates neurocognitive data, structural magnetic resonance imaging (sMRI), polygenic scores (PRS) for...

10.1001/jamapsychiatry.2020.3604 article EN cc-by JAMA Psychiatry 2020-12-02

It is widely hoped that statistical models can improve decision-making related to medical treatments. Because of the cost and scarcity outcomes data, this hope typically based on investigators observing a model's success in one or two datasets clinical contexts. We scrutinized optimism by examining how well machine learning model performed across several independent trials antipsychotic medication for schizophrenia. Models predicted patient with high accuracy within trial which was developed...

10.1126/science.adg8538 article EN Science 2024-01-11
Cassandra Wannan Barnaby Nelson Jean Addington Kelly Allott Alan Anticevic and 95 more Celso Arango Justin T. Baker Carrie E. Bearden Tashrif Billah Sylvain Bouix Matthew R. Broome Kate Buccilli Kristin S. Cadenhead Monica E. Calkins Tyrone D. Cannon Guillermo Cecci Eric Chen Kang Ik K. Cho Jimmy Choi Scott Clark Michael Coleman Philippe Conus Cheryl M. Corcoran Barbara A. Cornblatt Covadonga M. Díaz‐Caneja Dominic Dwyer Bjørn H. Ebdrup Lauren M. Ellman Paolo Fusar‐Poli Liliana Galindo Pablo A. Gaspar Carla Gerber Louise Birkedal Glenthøj Robert J. Glynn Michael P. Harms Leslie E. Horton René S. Kahn Joseph Kambeitz Lana Kambeitz‐Ilankovic John M. Kane Tina Kapur Matcheri S. Keshavan Sung‐Wan Kim Nikolaos Koutsouleris Marek Kubicki Jun Soo Kwon Kerstin Langbein Kathryn E. Lewandowski Gregory A. Light Daniel Mamah Patricia Marcy Daniel H. Mathalon Patrick D. McGorry Vijay A. Mittal Merete Nordentoft Ángela Núñez Ofer Pasternak Godfrey D. Pearlson Jesús Pérez Diana O. Perkins Albert R. Powers David R. Roalf Fred W. Sabb Jason Schiffman Jai Shah Stefan Smesny Jessica Spark William S. Stone Gregory P. Strauss Zailyn Tamayo John Torous Rachel Upthegrove Mark Vangel Swapna Verma Jijun Wang Inge Winter-van Rossum Daniel H. Wolf Phillip Wolff Stephen J. Wood Alison R. Yung Carla Agurto Mario Álvarez‐Jiménez G. Paul Amminger Marco Armando Ameneh Asgari-Targhi John D. Cahill Ricardo E. Carrión Eduardo Castro Suheyla Cetin‐Karayumak M. Mallar Chakravarty Youngsun Cho David Cotter Simon D’Alfonso Michaela Ennis Shreyas Fadnavis Clara Fonteneau Caroline X. Gao Tina Gupta Raquel E. Gur Ruben C. Gur

Abstract This article describes the rationale, aims, and methodology of Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ). is largest international collaboration to date that will develop algorithms predict trajectories outcomes individuals at clinical high risk (CHR) for psychosis advance development use novel pharmacological interventions CHR individuals. We present a description participating research networks data processing analysis coordination center, their processes...

10.1093/schbul/sbae011 article EN cc-by Schizophrenia Bulletin 2024-03-07

Magnetic resonance imaging-based markers of schizophrenia have been repeatedly shown to separate patients from healthy controls at the single-subject level, but it remains unclear whether these reliably distinguish mood disorders across life span and generalize new as well early stages illnesses. The current study used structural MRI-based multivariate pattern classification (i) identify cross-validate a differential diagnostic signature separating with first-episode recurrent (n = 158)...

10.1093/brain/awv111 article EN Brain 2015-05-01

Background: People at ultra high risk (UHR) of psychosis have an elevated developing a psychotic disorder, but it is difficult to predict which individuals will make transition frank illness. We investigated whether functional magnetic resonance imaging (fMRI) in conjunction with phonological fluency task presentation could distinguish subjects who subsequently developed from those did not. Methods: Sixty-five (41 UHR and 24 healthy controls) were assessed clinical using fMRI, verbal task....

10.1093/schbul/sbr194 article EN Schizophrenia Bulletin 2012-01-30

Identifying distinctive subtypes of schizophrenia could ultimately enhance diagnostic and prognostic accuracy. We aimed to uncover neuroanatomical chronic patients test whether stratification can computer-aided discrimination from control subjects. Unsupervised, data-driven clustering structural MRI (sMRI) data was used identify 2 drawn a US-based open science repository (n = 71) we quantified classification improvements compared controls 74) using supervised machine learning. externally...

10.1093/schbul/sby008 article EN Schizophrenia Bulletin 2018-01-26

Previous studies have shown that structural brain changes are among the best-studied candidate markers for schizophrenia (SZ) along with functional connectivity (FC) alterations of resting-state (RS) patterns. This study aimed to investigate effects clinical and sociodemographic variables on classification by applying multivariate pattern analysis (MVPA) both gray matter (GM) volume FC measures in patients SZ healthy controls (HC). RS magnetic resonance imaging data (sMRI) from 74 HC 71 were...

10.1093/schbul/sbw053 article EN Schizophrenia Bulletin 2016-07-01

Identifying psychosis subgroups could improve clinical and research precision. Research has focused on symptom subgroups, but there is a need to consider broader spectrum, disentangle illness trajectories, investigate genetic associations.To detect using data-driven methods examine their courses over 1.5 years polygenic scores for schizophrenia, bipolar disorder, major depression educational achievement.This ongoing multisite, naturalistic, longitudinal (6-month intervals) cohort study began...

10.1001/jamapsychiatry.2019.4910 article EN JAMA Psychiatry 2020-02-12
Coming Soon ...